Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles

Journal of Colloid and Interface Science

Volumn 481, Issue , 2016, Pages 107-116

  Soni, Namrata ^a   Soni, Neetu ^a   Pandey, Himanshu ^a   Maheshwari, Rahul ^b   Kesharwani, Prashant ^c   Tekade, Rakesh Kumar ^d,e  

^a SAM HIGGINBOTTOM UNIVERSITY OF AGRICULTURE   (India)

^b BM College of Pharmaceutical Education and Research   (India)

^c WAYNE STATE UNIVERSITY   (United States)

^d INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^e NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER AHMEDABAD   (India)

Author keywords

Drug delivery; Gemcitabine; Lung cancer; Solid lipid nanoparticles

Indexed keywords

BIOLOGICAL ORGANS; CELL CULTURE; CHEMOTHERAPY; CYTOLOGY; DISEASES; DRUG DELIVERY; EMULSIFICATION; NANOPARTICLES; SURFACE TREATMENT;

A549 LUNG ADENOCARCINOMA CELL LINES; CELLULAR TOXICITIES; CLINICAL APPLICATION; COMPLEX ENVIRONMENTS; GEMCITABINE; LUNG CANCER; SOLID LIPID NANOPARTICLE (SLN); SOLVENT EVAPORATION;

CELLS;

GEMCITABINE; MANNOSE; SOLID LIPID NANOPARTICLE; SOLVENT; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; LIPID; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG RELEASE; DRUG UPTAKE; EMULSION; EVAPORATION; FEMALE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CANCER; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; RING OPENING; SURFACE PROPERTY; ANALOGS AND DERIVATIVES; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; HUMANS; LIPIDS; LUNG NEOPLASMS; MANNOSE; NANOPARTICLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84979031454     PISSN: 00219797     EISSN: 10957103     Source Type: Journal    
DOI: 10.1016/j.jcis.2016.07.020     Document Type: Article

References (48)

1. [1] Imyanitov, E.N., Kuligina, E.S., Belogubova, E.V., Togo, A.V., Hanson, K.P., Drug Discov. Today Dis. Mech., 2, 2005, 213.
2. [2] Lee, W.-H., Loo, C.-Y., Traini, D., Young, P.M., Asian J. Pharm. Sci., 10, 2015, 481.
3. [3] Kesharwani, P., Tekade, R.K., Jain, N.K., Pharm. Res., 32, 2015, 1438.
4. [4] Sarris, E.G., Saif, M.W., Syrigos, K.N., Pharmaceuticals (Basel), 5, 2012, 1236.
5. [5] Whitsett, T.G., Inge, L.J., Dhruv, H.D., Cheung, P.Y., Weiss, G.J., Bremner, R.M., et al. Transl. Lung Cancer Res., 2, 2013, 273.
6. [6] Armstrong, T.S., Mendoza, T., Gning, I., Gring, I., Coco, C., Cohen, M.Z., et al. J. Neurooncol., 80, 2006, 27.
7. [7] Tekade, R.K., Youngren-Ortiz, S.R., Yang, H., Haware, R., Chougule, M.B., Mol. Pharm., 11, 2014, 3671.
8. [8] Travis, W.D., Brambilla, E., Noguchi, M., Nicholson, A.G., Geisinger, K., Yatabe, Y., et al. Proc. Am. Thorac. Soc., 6, 2012, 244.
9. [9] Allen, T.M., Nat. Rev. Cancer, 2, 2002, 750.
10. [10] Chopdey, P.K., Tekade, R.K., Mehra, N.K., Mody, N., Jain, N.K., J. Nanosci. Nanotechnol., 15, 2015, 1088.
11. [11] Jain, A., Agarwal, A., Majumder, S., Lariya, N., Khaya, A., Agrawal, H., et al. J. Control. Release, 148, 2010, 359.
12. [12] Ghanghoria, R., Tekade, R.K., Mishra, A.K., Chuttani, K., Jain, N.K., Nanomedicine (Lond.), 11, 2016, 797.
13. [13] Tekade, R.K., Tekade, M., Kumar, M., Chauhan, A.S., Pharm. Res., 32, 2015, 910.
14. [14] Maheshwari, R.G.S., Thakur, S., Singhal, S., Patel, R.P., Tekade, M., Tekade, R.K., Sci. Adv. Mater., 7, 2015, 1163.
15. [15] Parveen, S., Misra, R., Sahoo, S.K., Nanomedicine, 8, 2012, 147.
16. [16] Tekade, R.K., Maheshwari, R.G., Sharma, P.A., Tekade, M., Chauhan, A.S., Curr. Pharm. Des., 21, 2015, 4614.
17. [17] Thakur, S., Tekade, R.K., Kesharwani, P., Jain, N., J. Nanoparticle Res., 15, 2013, 1.
18. [18] Mody, N., Tekade, R.K., Mehra, N.K., Chopdey, P., Jain, N.K., AAPS PharmSciTech, 15, 2014, 388.
19. [19] Subedi, R.K., Kang, K.W., Choi, H.-K., Eur. J. Pharm. Sci., 37, 2009, 508.
20. [20] Joshi, M.D., Muller, R.H., Eur. J. Pharm. Biopharm., 71, 2009, 161.
21. [21] Imen, A., Amal, K., Ines, Z., Sameh, E.F., Fethi, E.M., Habib, G., Respir. Med., 100, 2006, 1463.
22. [22] Venishetty, V.K., Samala, R., Komuravelli, R., Kuncha, M., Sistla, R., Diwan, P.V., Nanomedicine, 9, 2013, 388.
23. [23] Nimje, N., Agarwal, A., Saraogi, G.K., Lariya, N., Rai, G., Agrawal, H., et al. J. Drug Target., 17, 2009, 777.
24. [24] Kumar, P.V., Asthana, A., Dutta, T., Jain, N.K., J. Drug Target., 14, 2006, 546.
25. [25] Jain, N.K., Tekade, R.K., Dendrimers for enhanced drug solubilization. Drug Delivery Strategies for Poorly Water-Soluble Drugs, 2013, John Wiley & Sons Ltd., 373–409.
26. [26] Gajbhiye, V., Barve, Narayanan G.J., Jain, N.K., Eur. J. Pharm. Sci., 48, 2013, 668.
27. [27] Soni, N., Jain, K., Gupta, U., Jain, N.K., J. Nanopart. Res., 17, 2015, 458.
28. [28] Bhadra, D., Yadav, A.K., Bhadra, S., Jain, N.K., Int. J. Pharm., 295, 2005, 221.
29. [29] Garg, M., Jain, N.K., J. Drug Target., 14, 2006, 1.
30. [30] Kesharwani, P., Tekade, R.K., Jain, N.K., Nanomedicine (Lond.), 9, 2014, 2291.
31. [31] Mansuri, S., Kesharwani, P., Tekade, R.K., Jain, N.K., Eur. J. Pharm. Biopharm., 102, 2015, 202.
32. [32] Kesharwani, P., Tekade, R.K., Gajbhiye, V., Jain, K., Jain, N.K., Nanomed. Nanotechnol. Biol. Med., 7, 2011, 295.
33. [33] Jain, S., Kesharwani, P., Tekade, R.K., Jain, N.K., Drug Dev. Ind. Pharm., 41, 2015, 722.
34. [34] Tekade, R.K., Chougule, M.B., Biomed. Res. Int., 2013, 2013, 712678.
35. [35] Dwivedi, P., Tekade, R.K., Jain, N.K., Curr. Nanosci., 9, 2013, 46.
36. [36] Gandhi, N.S., Tekade, R.K., Chougule, M.B., J. Control. Release, 194, 2014, 238.
37. [37] Agarwal, A., Gupta, U., Asthana, A., Jain, N.K., Biomaterials, 30, 2009, 3588.
38. [38] Prajapati, R.N., Tekade, R.K., Gupta, U., Gajbhiye, V., Jain, N.K., Mol. Pharm., 6, 2009, 940.
39. [39] Tekade, R.K., Dutta, T., Gajbhiye, V., Jain, N.K., J. Microencapsul., 26, 2009, 287.
40. [40] Jain, S.K., Gupta, Y., Jain, A., Saxena, A.R., Khare, P., Jain, A., Nanomedicine, 4, 2008, 41.
41. [41] Kesharwani, P., Tekade, R.K., Jain, N.K., Drug Discov. Today, 20, 2015, 497.
42. [42] Dutta, T., Jain, N.K., Biochim. Biophys. Acta, 1770, 2007, 681.
43. [43] Lu, W., Tan, Y.-Z., Hu, K.L., Jiang, X.-G., Int. J. Pharm., 295, 2005, 247.
44. [44] Shen, H., Shi, S., Zhang, Z., Gong, T., Sun, X., Theranostics, 5(7), 2015, 755.
45. [45] Agrawal, P., Gupta, U., Jain, N.K., Biomaterials, 28, 2007, 3349.
46. [46] Pandey, V., Gajbhiye, K.R., Soni, V., Drug Deliv., 22, 2015, 199.
47. [47] Sahu, P.K., Mishra, D.K., Jain, N., Rajoriya, V., Jain, A.K., Drug Deliv. Ind. Pharm., 41, 2015, 640.
48. [48] Shilpi, S., Vimal, V.D., Soni, V., Prog. Biomater., 4, 2015, 55.